11
68
Growth Score
1 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
446195
OncoInsight develops CAR-NK cell therapy, leveraging natural killer cells to target blood cancer and solid tumors.
About the Company
OncoInsight develops CAR-NK cell therapy, leveraging natural killer cells to target blood cancer and solid tumors. The company provides accessible cell therapies that enhance the killing potential of NK cells. They achieve this by incorporating a CAR protein that specifically binds to cancer cells, allowing the differentiated NK cells to
selectively attack and eliminate cancer cells. This approach enables clinicians to overcome the constraints associated with CAR-T treatments.
